We have identified exports a distinct growth driver for our present and long term growth objectives.

Our present export business is focused towards some prominently emerging markets like Sri lanka, Myanmar, Cambodia, Kenya, Mauritius and Jamaica.

We are committed towards providing global community with novel pharmaceutical products at the most affordable cost. Currently we are experiencing a great business growth in international markets of Asia and Africa, we are planning to take this success ahead in other emerging and regulated markets of the world.

To support these growth plans we are actively seeking alliances in Middle East and Central Asia, South and Central America.